Effect of clofibrate on the prevention of jaundice in term neonate
Not Applicable
- Conditions
- neonatal jaundice.Physiological jaundice (intense)(prolonged) NOS
- Registration Number
- IRCT2013031312803N1
- Lead Sponsor
- Babol University of Medical Sciences ,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Inclusion criteria :All term neonate (37 – 41 week of Gestational Age, 6/7) who are otherwise health and resulting from a non-complicated pregnancy
Exclusion criteria include: Term infants with overt jaundice in the first day after birth; Direct hyperbilirubinemia more than 1 mg/dl; Sick neonates; Infants born from mothers under phenobarbital treatment; Low birth weight neonate (birth weight less than 2500 gr); Preterm neonate (the gestational age less than 37 weeks) and neonates with Rh incompatibility.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total Bilirubin. Timepoint: Umbillical cord and 24,48,72 hours after birhbirth bilirubin. Method of measurement: with Bilirubinometer.
- Secondary Outcome Measures
Name Time Method